BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 14.0//EN
BEGIN:VTIMEZONE
TZID:Atlantic Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Atlantic Standard Time
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Atlantic Daylight Time
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:We can&rsquo\;t wait to see you at the OTS 2024! Stop by our ta
 ble to speak with our experts about how IDT&rsquo\;s CRISPR genome editing
  and gene regulation solutions can help you to move your project forward. 
 Our CRISPR product portfolio includes a comprehensive set of tools\, reage
 nts\, and services for all your genome editing needs\, including discovery
 \, preclinical research\, and clinical applications. Our gene expression p
 ortfolio includes ASOs\, dsiRNAs\, and miRNA inhibitors to enable you to a
 chieve high potency and high specificity in your loss-of-function studies.
 As your trusted partner\, we're committed to providing you with the highes
 t quality products and services to accelerate your research and bring your
  discoveries to life.Poster presentationEnd-to-End Tools for Interrogation
  of CRISPR-Cas Associated Genotoxicity\nMorgan Sturgeon\, PhD.CRISPR Appli
 cation Development Manager\, IDT\nFeatured productsCRISPR Genome Editing S
 olutions for your discovery and therapeutic development studiesAchieve\n h
 igher efficiency genome editing and avoid toxicity or innate immune respon
 ses with Alt-R&trade\; products.Gene regulation solutions for your researc
 hAchieve increased potency and better specificity\n    in loss-of-function
  studies using short oligos.
DTEND:20241009T210000Z
DTSTAMP:20260810T234127Z
DTSTART:20241006T100000Z
LOCATION:QC\,Canada\,Montreal\,Centre Mont-Royal
SEQUENCE:0
SUMMARY:IDT at OTS | 20th Annual Meeting of the  Oligonucleotide Therapeuti
 cs Society (2024)
UID:RFCALITEM639220020871701371
X-ALT-DESC;FMTTYPE=text/html:<p>We can&rsquo\;t wait to see you at the OTS 
 2024! Stop by our table to speak with our experts about how IDT&rsquo\;s C
 RISPR genome editing and gene regulation solutions can help you to move yo
 ur project forward. </p><p>Our CRISPR product portfolio includes a compreh
 ensive set of tools\, reagents\, and services for all your genome editing 
 needs\, including discovery\, preclinical research\, and clinical applicat
 ions. </p><p>Our gene expression portfolio includes ASOs\, dsiRNAs\, and m
 iRNA inhibitors to enable you to achieve high potency and high specificity
  in your loss-of-function studies.</p><p>As your trusted partner\, we're c
 ommitted to providing you with the highest quality products and services t
 o accelerate your research and bring your discoveries to life.</p><h2>Post
 er presentation</h2><p><a href="https://sfvideo.blob.core.windows.net/site
 finity/docs/default-source/poster/end-to-end-tools-for-interrogation-of-cr
 ispr-cas-associated-genotoxicity-poster.pdf?sfvrsn=79acce07_4">End-to-End 
 Tools for Interrogation of CRISPR-Cas Associated Genotoxicity</a>\n<br />M
 organ Sturgeon\, PhD.<br />CRISPR Application Development Manager\, IDT\n<
 /p><h2>Featured products</h2><p><a href="https://www.idtdna.com/pages/prod
 ucts/crispr-genome-editing">CRISPR Genome Editing Solutions for your disco
 very and therapeutic development studies</a><br />Achieve\n higher efficie
 ncy genome editing and avoid toxicity or innate immune responses with Alt-
 R&trade\; products.</p><p><a href="https://www.idtdna.com/pages/products/f
 unctional-genomics">Gene regulation solutions for your research</a><br />A
 chieve increased potency and better specificity\n    in loss-of-function s
 tudies using short oligos.</p>
END:VEVENT
END:VCALENDAR